GRUENDELPARTNER advises bm|t on growth financing for Active Medical Xcellence GmbH

Active Medical Xcellence GmbH, based in Jena, and bm|t beteiligungsmanagement thüringen gmbh have announced the successful completion of a seven-figure growth financing round. bm|t is investing in the medical technology company as lead investor via the Thüringer WachstumsBeteiligungsFonds II (WBF II). Other investors in this funding round include Mittelständische Beteiligungsgesellschaft Thüringen mbH (MBG Thüringen), Sparkasse Jena-Saale-Holzland and a business angel.

In recent years, AMX has developed into an innovative provider of medical technology solutions for urological endoscopy. With the MDR-approved activeCut morcellator, the company has a product that stands out for its high user-friendliness and innovative safety features. The funding is intended, in particular, to support the expansion of sales activities, international growth and the further development of the technology platform.

Through this investment, bm|t is investing in a technology-oriented company with high growth potential in an attractive market environment. For AMX, this marks the start of the next phase of development on its path to becoming a leading provider of innovative solutions for urological endoscopy.

GRUENDELPARTNER provided bm|t with comprehensive legal advice in connection with the transaction.

GRUENDELPARTNER’s M&A, Venture Capital and Private Equity practice group advises investors and companies on transactions at all stages of a company’s development. A particular focus is on supporting funding rounds, growth financing and exit processes.